Treatment of primary effusion lymphoma cell lines with lenalidomide - refine.bio

GSE60618

Homo sapiens

8 Downloadable Samples

Technology Badge Icon

Illumina HumanHT-12 V4.0 expression beadchip

Submitter Supplied Information

Description

Technical replicates from BC3 and BCBL1 cell lines were treated with DMSO or 5 micromoles of lenalidomide for 24 hours.

PubMed ID

Publication Title

Immunomodulatory drugs target IKZF1-IRF4-MYC axis in primary effusion lymphoma in a cereblon-dependent manner and display synergistic cytotoxicity with BRD4 inhibitors.

Total Samples

8

Submitter’s Institution

University of Southern California, Keck School of Medicine

Authors

Gopalakrishnan R, Matta H, Tolani B, Triche T Jr, Chaudhary PM

Source Repository

Gene Expression Omnibus (GEO)

No rows found

Loading...